Antibiotic combination
Patent 5721242 Issued on February 24, 1998. Estimated Expiration Date: 
February 24, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
February 24, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References2,4-Diamino-5-(4-amino and 4-dimethylamino-3,5-dimethoxy benzyl)pyrimidines 2,4-diamino-5-(1,2,3,4-tetrahydro-(substituted or unsubstituted)-6-quinolylmethyl)pyrimidines, useful as antimicrobials 2,4-diamino-5-(substituted)pyrimidines, useful as antimicrobials Process for the preparation of aqueous solutions of potentiated sulfonamides Patent #: 4599416 InventorsAssigneeApplicationNo. 241887 filed on 05/12/1994US Classes:514/272, Nitrogen bonded directly to the 1,3-diazine at 2-position514/646Benzene ring containingExaminersPrimary: Goldberg, Jerome D.Attorney, Agent or FirmForeign Patent References
International ClassesA61K 031/505A61K 031/135 Foreign Application Priority Data1993-06-17 CHAbstractPharmaceutical preparations containing an antibacterially-active synergistic combination of epiroprim and dapsone are useful in the treatment or control of infections caused by mycobacteria, Actinomycetes and toxoplasmosis pathogens.Other References
| |
